View of Randomized Controlled Trial of Rivaroxaban Plus Dual Antiplatelet Therapy versus Dual Antiplatelet Therapy Alone for Prevention of Left Ventricular Thrombus Formation after Acute Myocardial Infarction

Return to Article Details Randomized Controlled Trial of Rivaroxaban Plus Dual Antiplatelet Therapy versus Dual Antiplatelet Therapy Alone for Prevention of Left Ventricular Thrombus Formation after Acute Myocardial Infarction Download Download PDF